Aktuellt
SENASTE
Redeye expects strong performance from the Lifecare division in Q4 2024, though weaker results from the Wellness division will likely constrain overall growth. However, stable ARR growth should continue (stemming from license expansion in the Lifecare division) alongside a return to positive cash flow and sequential growth.
LÄS MER
